| Product NDC: | 53401-004 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | Ciprofloxacin |
| Active Ingredient(s): | 500 mg/1 & nbsp; Ciprofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53401-004 |
| Labeler Name: | Testpak Holding Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA007581 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091010 |
| Package NDC: | 53401-004-20 |
| Package Description: | 20 TABLET, COATED in 1 BOTTLE (53401-004-20) |
| NDC Code | 53401-004-20 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 20 TABLET, COATED in 1 BOTTLE (53401-004-20) |
| Product NDC | 53401-004 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciprofloxacin |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20091010 |
| Marketing Category Name | ANDA |
| Labeler Name | Testpak Holding Company |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |